V1.0 Extravasation: Clinical practice, patient experience & outcome
Research type
Research Study
Full title
THE MANAGEMENT OF CYTOTOXIC CHEMOTHERAPY EXTRAVASATION: A STUDY TO EXPLORE THE RELATIONSHIP BETWEEN CLINICAL PRACTICE, THE PATIENT EXPERIENCE & PATIENT REPORTED OUTCOME.
IRAS ID
164867
Contact name
Karen Harrold
Contact email
Sponsor organisation
East & North Hertfordshire NHS Trust
Duration of Study in the UK
0 years, 12 months, days
Research summary
This is the final stage of a PhD study to answer the research question: ‘what is the quality of our care, when saline washout is used as a strategy for managing vesicant and exfoliant chemotherapy extravasation?' Vesicant and exfoliant chemotherapy drugs are those that can cause severe ulceration if they leak (extravasate) from the vein into the surrounding skin if not dealt with quickly and effectively. Despite National policy aiming to improve the quality of NHS care and patient experience, a systematic review of the literature (Harrold et al 2015: in print)found no studies that evaluated the quality of care in extravasation management from the perspective of the patient.
The objective of this study, is to evaluate use of saline washout, to gain an understanding of the consequences of our actions in context to the clinical setting, the organisational influences and the patients and clinician’s perspectives and how interactions between ‘the organisation’ and the patient impact on the quality of care and the subsequent outcome. Its aims to answer the research sub-questions: 1. How is saline washout used in the clinical setting? 2. What are the ‘real world’ conditions when managing extravasation from the perspectives of all concerned? 3.How (and why) does this impact on the patient’s perception of the final outcome or end result?
Any area where chemotherapy is administered within Bedfordshire & Hertfordshire Cancer Network (B&HCN) and within the London Cancer Alliance (LCA) will be invited to participate; this will involve initial consultation meetings with staff, observation of practice in the clinical setting, 1:1 patient interviews, an examination of archival records and staff focus groups to discuss findings.
Recruitment of patients will continue for a maximum of 12 months or until no new information is forthcoming.
REC name
London - City & East Research Ethics Committee
REC reference
15/LO/1610
Date of REC Opinion
4 Nov 2015
REC opinion
Further Information Favourable Opinion